References
- Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-64 https://doi.org/10.1093/jnci/85.12.958
- Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796-802 https://doi.org/10.1093/jnci/87.11.796
- Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286: 3106-14 https://doi.org/10.1001/jama.286.24.3106
- Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. Human papillomavirus genotypes as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 1996; 69: 364-8 https://doi.org/10.1002/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3
- Remmink AJ, Walboomers JM, Helmerhorst TJ, Voorhorst FJ, Rozendaal L, Risse EK, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Int J Cancer 1995; 61: 306-11 https://doi.org/10.1002/ijc.2910610305
- Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-71 https://doi.org/10.1093/jnci/87.18.1365
- Ho GY, Palan PR, Basu J, Romney SL, Kadish AS, Mikhail M, et al. Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia. Int J Cancer 1998; 78: 594-9
- Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia. Lancet 1992; 339: 959-60 https://doi.org/10.1016/0140-6736(92)91532-D
- Bavin PJ, Giles JA, Deery A, Crow J, Griffiths PD, Emery VC, et al. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high-grade cervical disease in a population presenting with a mild dyskaryotic smear report. Br J Cancer 1993; 67: 602-5 https://doi.org/10.1038/bjc.1993.110
- Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific human papillomavirus DNA in abnormal scrapings as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 1994; 69: 167-71 https://doi.org/10.1038/bjc.1994.28
- Dalstein V, Riethmuller D, Pretet JL, Le Bail Carval K, Sautiere JL, Carbillet JP, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: A longitudinal French cohort study. Int J Cancer 2003; 106: 396-403 https://doi.org/10.1002/ijc.11222
- Hernandez-Hernandez DM, Ornelas-Bernal L, Guido-Jimenez M, Apresa-Garcia T, Alvarado-Cabrero I, Salcedo-Vargas M, et al. Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women. Gynecol Oncol 2003; 90: 310-7 https://doi.org/10.1016/S0090-8258(03)00320-2
- Park JS, Ryu HS, Chang SJ, Kim YM, Chang KH, Lee JP. The association of the cervical intraepithelial neoplasia and human papillomavirus viral Load. Korean J Obstet Gynecol 2005; 48: 2888-95
- Farthing A, Masterson P, Mason WP, Vousden KH. Human papillomavirus detection by hybrid capture and its possible clinical use. J Clin Pathol 1994; 47: 649-52 https://doi.org/10.1136/jcp.47.7.649
- Sun XW, Ferenczy A, Johnson D, Koulos JP, Lungu O, Richard RM, et al. Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol 1995; 173: 1432-7 https://doi.org/10.1016/0002-9378(95)90629-0
- Sailors J, Gander R, Saboorian MH, Berkley P, Foster B, Ashfaq R. Stability of PreservCyt for Hybrid Capture (HC II) HPV test. Diagn Cytopathol 2005; 32: 260-3 https://doi.org/10.1002/dc.20232
- Hubbard RA. Human Papillomavirus testing methods. Arch Pathol Lab Med 2003; 127: 940-5
- Bolick DR, Bolick RE, Coates F, Daniels CM, Juretich MB, Lin KK, et al. Laboratory implementation of human papillomavirus testing. Arch Pathol Lab Med 2003; 127: 984-90
- Castle PE, Lorincz AT, Mielzynska-Lohnas I, Scott DR, Glass AG, Sherman ME, et al. Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible. J Clin Microbiol 2002; 40: 1088-90 https://doi.org/10.1128/JCM.40.3.1088-1090.2002
- Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, et al. Shanxi province cervical cancer screening study: A cross sectional comparativetrial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001; 83: 439-44 https://doi.org/10.1006/gyno.2001.6370
- Wright Jr TC, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283: 81-6 https://doi.org/10.1001/jama.283.1.81
- Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening: Results from women in a high risk province of Costa Rica. JAMA 2000; 283: 87-93 https://doi.org/10.1001/jama.283.1.87
- Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC, et al. Human papillomavirus DNA testing for cervical cancer screening in low resource settings. J Natl Cancer Inst 2000; 92: 818-25 https://doi.org/10.1093/jnci/92.10.818
- Bozzetti M, Nonnenmacher B, Mielzinska II, Villa L, Lorincz A, Breitenbach VV, et al. Comparison between hybrid capture II and polymerase chain reaction results among women at low risk for cervical cancer. Ann Epidemiol 2000; 10: 466
- Park JY, Lee KH, Dong SM, Kang S, Park SY, Seo SS. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization. Gynecol Oncol 2008; 108: 549-54 https://doi.org/10.1016/j.ygyno.2007.11.009
- Riou G, Favre M, Jeannel D, Bourhis J, Le Doussal V, Ortho G. Association between poor prognosis in early stage invasive cervical carcinoma and non-detection of HPV DNA. Lancet 1990; 335: 1171-4 https://doi.org/10.1016/0140-6736(90)92693-C
- Datta NR, Kumar P, Singh S, Gupta D, Srivastava A, Dhole TN. Does pretreatment human papillomavirus titers predict radiation response and survival outcomes in cancer cervix? Gynecol Oncol 2006; 103: 100-5 https://doi.org/10.1016/j.ygyno.2006.01.058